Format

Send to

Choose Destination
See comment in PubMed Commons below
Appl Health Econ Health Policy. 2013 Jun;11(3):307. doi: 10.1007/s40258-013-0025-1.

Authors' reply to Alatorre et al.: "cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison".

PMID:
23592392
PMCID:
PMC3663979
DOI:
10.1007/s40258-013-0025-1
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center